Home / Netherlands / Pharming Group N.V.
Pharming Group N.V.
Short position disclosed on September 18, 2026.
7.34% of the capital sold short
10 disclosing funds
1,141 disclosures on record
NL0010391025 ISIN code
Evolution of the disclosed total
0%2.5%5%7.5%10%
Oct 2025Jan 2026Apr 2026Jul 2026
January 23, 2014 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Citadel Advisors LLC | 1.31% | +0.48 pt | September 16, 2026 | |
| Two Sigma Investments, LP | 1.28% | new | September 1, 2026 | |
| Capstone Volatility Master (Cayman) Limited | 0.72% | -0.31 pt | September 11, 2026 | |
| Walleye Capital LLC | 0.67% | new | September 15, 2026 | |
| D. E. Shaw & Co., L.P. | 0.65% | new | September 18, 2026 | |
| Lazard Asset Management LLC | 0.59% | +0.01 pt | September 9, 2026 | |
| Whitebox Advisors LLC | 0.58% | new | June 3, 2026 | |
| Spark Investment Management LLC | 0.52% | new | June 19, 2026 | |
| AQR Capital Management, LLC | 0.51% | new | September 11, 2026 | |
| Jupiter Asset Management Ltd. | 0.51% | new | September 11, 2026 |
In the United States PHGUF (OTC): 12,050,531 shares sold short on August 31, 2026. FINRA names no fund.
On the other side: the funds that hold Pharming Group N.V. Titelia
Get the moves on Pharming Group N.V. by mail.
No account: one address, one link to confirm, one link to stop in every message.
History of disclosures
Download 1141 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in the Netherlands
- Akzo Nobel N.V. 9.59% of the capital sold short
- Signify N.V. 7.02% of the capital sold short
- Imcd N.V. 4.86% of the capital sold short
- Fugro N.V. 3.69% of the capital sold short
- DSM-Firmenich AG 3.48% of the capital sold short
- Basic-Fit N.V. 3.43% of the capital sold short
- NSI N.V. 2.59% of the capital sold short
- Alfen N.V. 1.98% of the capital sold short
- Arcadis N.V. 1.72% of the capital sold short
- Sligro Food Group N.V. 1.55% of the capital sold short
- PostNL N.V. 1.52% of the capital sold short
- Avantium N.V. 1.39% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Pharming Group N.V., source AFM, data as at September 18, 2026, https://www.quivad.com/action/pharming-group-n-v?page=2